PubMed · 1977 · 55 citations · 14 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyBiochemical ToxicologyDrug MetabolismDrug-metabolizing EnzymesGlutathione ConjugationGlutathione MetabolismMetabolite IdentificationMolecular Mechanisms Of ToxicityAlkylation ProcessesAlkylation ReactionsCarcinogenic PathwaysMass Spectral Data AnalysisNuclear Magnetic Resonance StudiesPhosphate Buffer SystemPlant AlkaloidsPyrrolizidine Alkaloids
The covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione, has been investigated. Dehydroretronecine was allowed to react with cysteine and glutathione in an in vitro system of phosphate buffer solutions. The reaction products were identified structurally by chromatographic, nuclear magnetic resonance, infrared, ultraviolet, and mass-spectral analysis. These data indicate that the reaction products are the sulfhydryl-linked 7-thiocysteine-dehydroretronecine and 7-thioglutathione-dehydroretronecine. Active alkylation of sulfhydryl groups is a possible mechanism by which these alkaloids interact with cellular components.
14
PYRROLIZIDINE ALKALOIDS AS ALKYLATING AND ANTIMITOTIC AGENTS*
CCJ Culvenor, D. T. Downing, J. A. Edgar et al. · Annals of the New York Academy of Sciences · 1969 · 105 citations
Malignant tumors in rats given lasiocarpine.
Donald J. Svoboda, Janardan K. Reddy · PubMed · 1972 · 90 citations
Medicine, Oncology, Pharmacology +15